Inhaltsseite: Home

ZKB Mini-Future Long auf
Basilea Pharmaceutica AG

ISIN: CH1281039391 Security: 128103939 Symbol: IBSA4Z Life cycle
Secondary market

Bid Price 0.32

Ask Price 0.33

Currency CHF

Exchange SIX Structured Products

Volume 100'000.00

Volume 100'000.00

Date/time (delayed) 16.05.2024 05:15:01

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 17.05.2024
Key Information Document DE 17.05.2024
Key Information Document EN 17.05.2024
Key Information Document FR 17.05.2024
Key Information Document IT 17.05.2024

Price data

  Bid Ask
Price 0.32 0.33
Volume 100'000.00 100'000.00
Date/time 16.05.24 17:15 16.05.24 17:15

Current data

Last price paid 0.32
Change +6.67% [ +0.02 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time 14.05.2024 17:20

Life cycle

Fixingn.a.
Settlement date10.11.2023
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue +116.67%
Year to date (YTD) +88.24%
1 month +23.08%
3 months +68.42%
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.15
Underlying price on issue35.80
Premium0.03%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1281039391
Symbol IBSA4Z
Security 128103939
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Basilea Pharmaceu N, CH0011432447
Underlying ISIN CH0011432447
Funding level 29.530300
Stop-loss level 30.345500
Distance to stop-loss level 31.50%
Long/Short type Long
Subscription ratio 50.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 08.11.2023

Key figures

Premium 3.32%
Premium p.a. n.a.
Leverage 2.73
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 14.774300
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Ajax loading